visceral adiposity raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-08 and is reviewed periodically as new material appears.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
== Early life == Carlisle was selected by Essendon with pick 24 in the 2009 National Draft. Like fellow draftee Jake Melksham, he is a local to the Essendon area. He played with the Calder Cannons in the TAC Cup and Craigieburn in the EDFL. He represented Vic Metro in the 2009 AFL National Under 18 Championships and was part of the 2009 Premiership team.
=== Onset and duration === The psychoactive effects of LSD last on average between 7 and 11 hours, with a possible range of 4 to 22 hours. Higher doses tend to lead to a longer duration of action. The onset of action when administered orally is 0.4 to 1.0 hours on average, with a possible range of 0.1 to 1.8 hours. The time to peak effects given orally is 2.2 to 2.8 hours on average, with a range of 1.3 to 6.5 hours. The duration of LSD can be shortened through the use of trip killers or shorteners like ketanserin. In a clinical trial, ketanserin given 1 hour after LSD shortened its duration from 8.5 hours to 3.5 hours or by about 60%.
Cresskill is governed under the borough form of New Jersey municipal government, which is used in 218 municipalities (of the 564) statewide, making it the most common form of government in New Jersey. The governing body is comprised of the mayor and the borough council, with all positions elected at-large on a partisan basis as part of the November general election. A mayor is elected directly by the voters to a four-year term of office. The borough council includes six members elected to serve three-year terms on a staggered basis, with two seats coming up for election each year in a three-year cycle. The borough form of government used by Cresskill is a "weak mayor / strong council" government in which council members act as the legislative body with the mayor presiding at meetings and voting only in the event of a tie. The mayor can veto ordinances subject to an override by a two-thirds majority vote of the council. The mayor makes committee and liaison assignments for council members, and most appointments are made by the mayor with the advice and consent of the council. As of 2026, the mayor of the Borough of Cresskill is Republican John Morgan, who was appointed to serve a term of office ending on December 31, 2027. Members of the Cresskill Borough Council are Saverio Costa (R, 2028), Cheryl Furio (R, 2028), Arthur J. McLaughlin (D, 2026), Hector Olmo (R, 2026), Kathleen Savas (D, 2027), and Kathy M. Schultz-Rummel (R, 2027).
== Chemistry == Mitragynine pseudoindoxyl was first accessible via biomimetic semisynthesis from mitragynine. Total synthesis of an unnatural analogue was reported featuring an interrupted Ugi reaction as the key step. Scalable and modular total synthesis of the natural product has also been accomplished using a chiral pool based strategy. This study also demonstrated structural plasticity in biological systems.
Sources: en.wikipedia.org
==== Sexual misconduct and resignation ==== A $279,000 payoff for the silence of Jessica Hahn, who alleged that Bakker and former PTL Club co-host John Wesley Fletcher drugged and raped her, was paid with PTL funds through Bakker's associate Roe Messner. Bakker, who made PTL's financial decisions, allegedly kept two sets of books to conceal accounting irregularities. Reporters for The Charlotte Observer, led by Charles Shepard, investigated PTL's finances and published a series of articles. On March 19, 1987, after the disclosure of a payoff to Hahn, Bakker resigned from PTL. Although he acknowledged that he had a sexual encounter with Hahn at a hotel room in Clearwater, Florida, he denied raping her. Bakker was also the subject of homosexual and bisexual allegations made by Fletcher and PTL director Jay Babcock, which Bakker denied under oath. Rival televangelist John Ankerberg appeared on Larry King Live and made several allegations of moral impropriety against Bakker, which both Bakkers denied. Bakker was succeeded as PTL head by the Rev. Jerry Falwell of Thomas Road Baptist Church in Lynchburg, Virginia. Bakker chose Falwell as his successor because he feared that fellow televangelist Jimmy Swaggart, who had initiated an Assemblies of God investigation into Bakker's sexual misconduct, was attempting to take over his ministry. Bakker believed that Falwell would temporarily lead the ministry until the scandal died down, but on April 28, 1987, Falwell barred Bakker from returning to PTL.
In August 2015, Arby's introduced a series of five small sandwiches called Sliders starting at $1.29, with prices varied by location. These new menu items led to an increase in sales at many locations. This is not the first time Arby's tried to market miniature sandwiches. Two years earlier, Arby's tried to sell a similar product called the Mighty Minis that were sold in pairs. During the first month of national sales, the firm was able to sell 1 million or a ton of sliders. To encourage additional sales outside normal lunch and dinner meal hours, began to offer sliders and small size drinks and sides at the reduced price of $1 between the hours of 2 and 5 p.m. starting in October 2015. Due to Arby's great success in the increase of sales created by the introduction of this new product line, Nation's Restaurant News awarded Arby's its MenuMasters Award for 2016. The Turkey 'n Cheese was initially offered as a limited time menu item in December 2016 but was shown to be popular enough to be retained on the regular menu. A Pizza Slider was introduced as a limited time menu item in May 2017. In late August 2016, Arby's introduced four chicken sandwiches that used a buttermilk-based breaded breast filet. Arby's debuted a new sandwich known as Smokehouse Pork Belly Sandwich in October 2016.
As in the 2023 election, the electoral system followed that of the 2021 amendment of the 2017 constitution. The 500 members of the House of Representatives were elected by parallel voting. 400 seats were elected from single-member constituencies by first-past-the-post voting and 100 seats by proportional representation. Voters cast separate ballots for the two sets of seats. The 100 party-list seats were distributed under the "100 divisor" formula, restored in 2022 after parliament failed to finalise a rival draft within its 180-day deadline. The national party-list vote is divided by 100 to give a quota; each party takes one seat for every whole quota it has won, and the seats still unfilled go to the parties with the largest fractional remainders. List seats are awarded on top of constituency seats rather than in compensation for them, so a party that sweeps the constituencies keeps its full proportional entitlement as well. Writing shortly before the system was first used, Napon Jatusripitak of the ISEAS–Yusof Ishak Institute observed that cutting the number of list seats from 150 to 100 raised the share of the vote needed to win one and allowed larger parties to take a higher proportion of seats than of votes. At the 2026 election the 35,030,579 valid party-list votes produced a quota of 350,306.
Since uranium and plutonium are nuclear weapons materials, there are proliferation concerns. Ordinarily (in spent nuclear fuel), plutonium is reactor-grade plutonium. In addition to plutonium-239, which is highly suitable for building nuclear weapons, it contains large amounts of undesirable contaminants: plutonium-240, plutonium-241, and plutonium-238. These isotopes are extremely difficult to separate, and more cost-effective ways of obtaining fissile material exist (e.g., uranium enrichment or dedicated plutonium production reactors). High-level waste is full of highly radioactive fission products, most of which are relatively short-lived. This is a concern since if the waste is stored, perhaps in deep geological storage, over many years the fission products decay, decreasing the radioactivity of the waste and making the plutonium easier to access. The undesirable contaminant Pu-240 decays faster than the Pu-239, and thus the quality of the bomb material increases with time (although its quantity decreases during that time as well). Thus, some have argued, as time passes, these deep storage areas have the potential to become "plutonium mines", from which material for nuclear weapons can be acquired with relatively little difficulty. Critics of the latter idea have pointed out the difficulty of recovering useful material from sealed deep storage areas makes other methods preferable. Specifically, high radioactivity and heat (80 °C in surrounding rock) greatly increase the difficulty of mining a storage area, and the enrichment methods required have high capital costs.
===== Bulgaria ===== In 2020, Bulgaria became the first country in the European Union to allow retail sales of food products and supplements containing CBD, despite the ongoing discussion within the EU about the classification of CBD as a novel food. However, there exists a legal gap because of the lack of a legally-permissible minimum amount of THC in the products containing cannabinoids.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.